5AM Ventures is a prominent venture capital firm in the United States. It aims at developing the industry of life sciences to another level of new technology.
This is done by supporting companies in the industry to grow in such a way that they can make good returns for the investors. 5AM Ventures support willing companies that can conduct research in the medical field to come up with new breakthroughs that can solve some of the medical challenges experienced by humanity today. Read more: Scott Racklage | Bloomberg
The idea behind 5AM is a noble one and that can help even the generations to come. 5AM steps in to help governments and world health organizations too address the issue of health care which is undoubtedly one of the single most crucial areas of human existence.
Today the world is focused on looking for solutions to ailments such as diabetes, cancer and other chronic diseases that have not yet been subdued completely from the face of the earth. The company also engages in helping organizations that engage in providing diagnosis and other preventive medication for a wide range of diseases or medical conditions.
5AM has invested in its personnel, who are professionals in the areas of medical, science, legal, finance and operational expertise. Once this expertise is brought together you get a combination of skills that will definitely raise any company from scratch to probably a multinational level with no risk for failure. Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift
5AM takes over the formation of companies and put structures that will see a company grow. Mostly, they take short term roles in running of the business ventures. In other cases, they sit on the board of companies they are helping to form. They also participate in the recruitment of the companies while they still in their early stages of formation.
At the helm of 5AM management team is Scott Rocklage. He is the managing partner of 5AM Ventures. He joined the organization in 2003. Scott Rocklage has served as the CEO of EPIRUS Biopharmaceuticals besides being the president of Amersham Health. Not only these two positions have Scott Rocklage served for, he has been to tens of organizations in various positions from board member to the president of the said organizations.
All these positions have assisted him to develop immense knowledge and experience on how to create companies and make them achieve the goals they were destined to. Scott Rocklage is a graduate of the University of California, Berkeley with a B.S in Chemistry.